Recombinanat Toxoplasma gondii is an Escherichia coli-derived recombinant protein corresponding to amino acids 24-100 of Toxoplasma gondii dense granule protein 7, also known as 29 kDa excretory dense granule protein, p29/GRA7 or p29.
- Target Species
- Product Form
- Purified Recombinant Protein - liquid
- Buffer Solution
- 50mM Tris-HCl
- Preservative Stabilisers
- 50% Glycerol
- >95% by SDS PAGE
- Approx. Protein Concentrations
- Total protein concentration 1.0mg/ml
- Store at -20oC only.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the protein. Should this product contain a precipitate we recommend microcentrifugation before use.
- 12 months from date of despatch
- GO Terms
integral to membrane
symbiont-containing vacuole membrane
- For research purposes only
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Applications of Toxoplasma gondii p29 GRA7
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Copyright © 2021 Bio-Rad Antibodies (formerly AbD Serotec)
How to Use the Spectraviewer?
Start by selecting the application you are interested in, with the option to select an instrument from the drop down menu or create a customized instrument
Select the fluorophores or fluorescent proteins you want to include in your panel to check compatibility
Select the lasers and filters you wish to include
Select combined or multi-laser view to visualize the spectra